16
Effectiveness of Heart Rate Variability Biofeedback Intervention in Treating Post-Concussion Symptoms Within Three Months After Mild Traumatic Brain Injury
Chi-Cheng Yang, National Chengchi University, Taipei, Taiwan
Richard Gevirtz, California School of Professional Psychology at Alliant International University, San Diego, United States
Mild traumatic brain injuries (mTBIs) are usually accompanied by post-concussion syndrome (PCS). Heart rate variability biofeedback (HRV-BF) has been shown to validate the neuro-peripheral relationship and enhance the interaction between top-down and bottom-up processes. A few studies have investigated the PCS treatment effects of HRV-BF in traumatic brain injury, but none have examined the treatment effect for each symptom of post-concussion syndrome. This study aimed to investigate the effectiveness of HRV-BF intervention for 16 commonly reported symptoms associated with mTBI and three PCS domains.
Forty-one participants with mTBI were referred from the neurosurgery outpatient clinic and randomly assigned to a psychoeducation group or an HRV-BF intervention group. The psychoeducation group received standard medical care and one 60-minute psychoeducation session. The HRV-BF group received standard medical care and one 60-minute session of the HRV-BF intervention weekly for 10 weeks. All participants completed a pre-, mid-, and post-test of the PCS self-reported measure at week 1 (pre-test), week 4 (mid-test), and week 12 (post-test), and generalized estimating equations (GEE) for repeated measures were used to estimate the intervention effects of the two groups.
Participants in the HRV-BF group experienced greater reduction in headache (β = -1.21, p < .001; β = -1.16, p < .001), dizziness (β = -.83, p = .003; β = -.83, p = .01), fatigue (β = -.88, p = .002; β = -1.07, p < .001), vomiting (β = -.45, p = .045; β = -.65, p = .039), insomnia (β = -.79, p = .003; β = -.89, p = .009), loss of energy (β = -.91, p < .001; β = -.96, p = .001), memory impairment (β = -.84, p < .001; β = -1.04, p < .001), psychomotor slowing (β = -.90, p < .001; β = -.80, p = .005), attention deficit (β = -.89, p < .001; β = -1.29, p < .001), depression (β = -.54, p = .009; β = -.78, p < .001), anxiety (β = -.55, p = .048; β = -.75, p = .009), and irritability (β = -.50, p = .049; β = -.54, p = .027) compared to the psychoeducation group at week 4 and week 10. Further subdividing symptoms into three domains, the HRV-BF group experienced greater reduction in physical (β = -.607, p < .001; β = -6.82, p < .001), cognitive (β = -2.62, p < .001; β = -3.13, p < .001), and emotional symptoms (β = -1.58, p < .001; β = -2.07, p < .001) compared to the psychoeducation group at week 4 and week 10.
The HRV-BF intervention was found to be more effective and efficient in reducing most post-concussion symptoms for participants with mTBI, and the improvement of physical symptoms was greater than that for cognitive and emotional symptoms.
Keyword 1: treatment outcome
Keyword 2: neuromodulation
Keyword 3: traumatic brain injury